![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|15|3|171-185
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.3, 2015-01, pp. : 171-185
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NF-κB – a target in the inflammation of bone destruction
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology, Vol. 7, Iss. 2, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Development of novel therapeutic strategies that target HIF-1
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)